Express News | Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024
Why Tempus AI (TEM) Stock Is Rising
Tempus AI Inc (NASDAQ:TEM) shares are trading higher by 7.45% to $35.82 during Tuesday's session after the company announced it was granted Advanced Diagnostic Laboratory Test (ADLT) status for its ne
Express News | Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for Its XT CDx Test
Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted Advanced Diagnostic Laboratory Test
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Tempus AI, Inc. (NASDAQ:TEM) shares jumped 30.43% after the company announced it received U.S. FDA 510(k) cle
Express News | Tempus AI Rises for Third Straight Session, Last up 7.3%
Masayoshi Son's SoftBank To Raise $1.86B Through Bond Issuance For AI Investment And Debt Repayment
Japanese multinational conglomerate SoftBank Group Corp. (OTC:SFTBY) has announced its intention to issue bonds worth approximately $1.86 billion. The proceeds will be directed towards the repayment o
SoftBank Group Launches AI Healthcare Joint Venture With Tempus AI
Express News | Tempus AI Shares Are Trading Higher After the Company Announced It Received U.S. FDA 510(k) Clearance for Tempus ECG-AF Device That Uses AI to Help Identify Patients Who May Be at Increased Risk of Atrial Fibrillation/flutter
Tempus Wins FDA Nod for AI-backed Heart Diagnostic
Tempus AI Gets 510(k) Clearance for ECG-AF Device
By Chris Wack Tempus AI said it received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-AF device, which uses artificial intelligence to help identify patients who may
Express News | Tempus Receives U.S. FDA 510(K) Clearance for Tempus Ecg-Af, an AI-Based Algorithm That Identifies Patients at Increased Risk of Afib
This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan
SoftBank Group (OTC:SFTBY) (OTC:SFTBF) is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service wil
Express News | Tempus To Collaborate With United Therapeutics To Study Use Of AI To Detect Patients At Risk For Pulmonary Hypertension
Express News | Tempus AI Inc: Collaboration With United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
Express News | SoftBank Group to Set up Medical Data Joint Venture With US-Based Tempus AI -Nikkei
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be
Express News | Shares of SoftBank-Backed Tempus AI Down More Than 16%, Well Below IPO Price in Their Third Day of Trading
Express News | Tempus AI Shares Are Trading Lower Amid Post-IPO Volatility
Tempus AI Prices 11.1M Share IPO at $37/sh